Cargando…
Attitudes towards open‐label versus placebo‐control designs in oncology randomized trials: A survey of medical oncologists
RATIONALE, AIMS AND OBJECTIVES: Randomized trials are considered the gold standard when assessing the efficacy of new therapeutic agents. In clinical situations where no standard of care therapy is approved, randomized trials usually compare experimental agents to either a placebo or an open‐label n...
Autores principales: | Kushnir, Igal, Clemons, Mark, Fergusson, Dean, Bossé, Dominick, Reaume, Martin Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302988/ https://www.ncbi.nlm.nih.gov/pubmed/35191169 http://dx.doi.org/10.1111/jep.13669 |
Ejemplares similares
-
Perceptions and attitudes of medical oncologists regarding fertility preservation and pregnancy in high‐risk cancer patients: A survey among Canadian medical oncologists
por: Alshamsan, Bader, et al.
Publicado: (2022) -
Oncologists’ Attitudes Toward Cancer Care Affordability
por: Aviki, Emeline M., et al.
Publicado: (2022) -
De-escalated administration of bone-targeted agents in patients with breast and prostate cancer—A survey of Canadian oncologists
por: Hutton, Brian, et al.
Publicado: (2013) -
Oncologists' attitudes toward KRAS testing: a multisite study
por: Harris, Julie N, et al.
Publicado: (2013) -
Iranian Oncologists’ Attitude towards Fertility Preservation in a Sample Group
por: Ghorbani, Behzad, et al.
Publicado: (2011)